Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials.
Ingels J, De Cock L, Mayer RL, Devreker P, Weening K, Heyns K, Lootens N, De Smet S, Brusseel M, De Munter S, Pille M, Billiet L, Goetgeluk G, Bonte S, Jansen H, Lint SV, Leclercq G, Taghon T, Menten B, Vermaelen K, Impens F, Vandekerckhove B.
Ingels J, et al. Among authors: de munter s.
Cytotherapy. 2022 Feb;24(2):213-222. doi: 10.1016/j.jcyt.2021.08.005. Epub 2021 Oct 22.
Cytotherapy. 2022.
PMID: 34696961
Free article.